Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of ≤500/μL

被引:43
|
作者
Watts, DH
Lambert, JS
Stiehm, ER
Bethel, J
Whitehouse, J
Fowler, MG
Read, J
机构
[1] NICHHD, Pediat Adolescent & Maternal AIDS Branch, Bethesda, MD 20892 USA
[2] Univ Maryland, Inst Human Virol, Rockville, MD USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] NIAID, Div AIDS, Bethesda, MD 20892 USA
关键词
postpartum complications; human immunodeficiency virus-infected women;
D O I
10.1067/mob.2000.105423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We sought to describe rates of and risk factors for complications by delivery mode among human immunodeficiency virus-infected women with CD4 counts of less than or equal to 500/mu L. STUDY DESIGN: Complication rates were calculated by delivery mode, as follows: planned cesarean delivery performed without labor or rupture of membranes, other cesarean delivery performed after labor or rupture of membranes, or vaginal delivery. Risk factors were evaluated. RESULTS: Major complications in the planned cesarean delivery (n = 37), other cesarean delivery (n = 95), and vaginal delivery (n = 365) groups were amnionitis or endometritis (16%, 27%, and 7%, respectively), wound infection (5%, 8%, and <1%, respectively), and transfusion (8%, 6%, and 3%, respectively). Any peripartum infection occurred among 16 (18%) of those with a CD4 count of <200/mu L and 43 (13%) with a CD4 count of greater than or equal to 200/mu L (P = .17). On multivariate analyses, factors associated with amnionitis-endometritis were cesarean delivery and African American race, and a factor associated with transfusion was third-trimester anemia. CONCLUSION: Endometritis and wound infection occurred more frequently among human immunodeficiency virus-infected women after cesarean than among women undergoing vaginal delivery; however, complication rates overall were within the range reported in human immunodeficiency virus-negative women, Measures to decrease complications in human immunodeficiency virus-infected women, such as greater use of prophylactic antibiotics, should be assessed.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 50 条
  • [41] The Implications of Low Absolute CD4 Counts in Patients With Cirrhosis and Human Immunodeficiency Virus
    Sullivan, Timothy
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (02):
  • [42] CD4 COUNTS AS PREDICTORS OF OPPORTUNISTIC PNEUMONIAS IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
    MASUR, H
    OGNIBENE, FP
    YARCHOAN, R
    SHELHAMER, JH
    BAIRD, BF
    TRAVIS, W
    SUFFREDINI, AF
    DEYTON, L
    KOVACS, JA
    FALLOON, J
    DAVEY, R
    POLIS, M
    METCALF, J
    BASELER, M
    WESLEY, R
    GILL, VJ
    FAUCI, AS
    LANE, HC
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (03) : 223 - 231
  • [43] CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis
    Jones, BE
    Oo, MM
    Taikwel, EK
    Qian, DJ
    Kumar, A
    Maslow, ER
    Barnes, PF
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 988 - 991
  • [44] SOLUBLE CD4 LEVELS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS
    REDDY, MM
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01): : 246 - 246
  • [45] Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons
    Orlikowsky, TW
    Wang, ZQ
    Dudhane, A
    Dannecker, GE
    Niethammer, D
    Wormser, GP
    Hoffmann, MK
    Horowitz, HW
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1328 - 1330
  • [46] CD4 CELL COUNT CRITERIA TO DETERMINE WHEN TO INITIATE ANTIRETROVIRAL THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
    Wongsawat, Jurai
    Puthanakit, Thanyawee
    Kanjanavanit, Suparat
    Hansudewechakul, Rawiwan
    Ngampiyaskul, Chaiwat
    Kerr, Stephen J.
    Ubolyam, Sasiwimol
    Suwanlerk, Tulathip
    Kosalaraksa, Pope
    Luesomboon, Wicharn
    Ngo-Giang-Huong, Nicole
    Chandara, Mom
    Saphonn, Vonthanak
    Ruxrungtham, Kiat
    Ananworanich, Jintanat
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 966 - 968
  • [47] IMMUNIZATION OF SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED RHESUS-MONKEYS WITH SOLUBLE HUMAN CD4 ELICITS AN ANTIVIRAL RESPONSE
    WATANABE, M
    LEVINE, CG
    SHEN, L
    FISHER, RA
    LETVIN, NL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) : 4616 - 4620
  • [48] Low Risk of CD4 Decline After Immune Recovery in Human Immunodeficiency Virus-Infected Children With Viral Suppression
    Kosalaraksa, Pope
    Boettiger, David C.
    Bunupuradah, Torsak
    Hansudewechakul, Rawiwan
    Saramony, Sarun
    Do, Viet C.
    Sudjaritruk, Tavitiya
    Yusoff, Nik K. N.
    Razali, Kamarul A. M.
    Nguyen, Lam V.
    Nallusamy, Revathy
    Fong, Siew M.
    Kurniati, Nia
    Truong, Khanh H.
    Sohn, Annette H.
    Chokephaibulkit, Kulkanya
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2017, 6 (02) : 173 - 177
  • [49] HUMAN HERPESVIRUS-6 DNA IN BLOOD-CELLS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN - CORRELATION OF HIGH-LEVELS WITH HIGH CD4 CELL COUNTS
    FAIRFAX, MR
    SCHACKER, T
    CONE, RW
    COLLIER, AC
    COREY, L
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06): : 1342 - 1345
  • [50] The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China
    Hong-Yun Zhang
    Man-Dong Fei
    Yong Jiang
    Qiu-Yue Fei
    Hong Qian
    Lin Xu
    Yu-Ni Jin
    Cheng-Qin Jiang
    Hai-Xia Li
    Sarah M Tiggelaar
    Jennifer S Smith
    Vikrant V Sahasrabuddhe
    You-Lin Qiao
    Virology Journal, 11